Description
VORANIGO is an isocitrate dehydrogenase-1 (IDH1) and isocitrate dehydrogenase-2 (IDH2) inhibitor indicated for the treatment of adult and pediatric patients 12 years and older with Grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation, as detected by an FDA-approved test, following surgery including biopsy, sub-total resection, or gross total resection.
Additional information
| Brand | VORANIGO® |
|---|---|
| Generic name | Vorasidenib tablets |
| Form | Oral tablets |
| Strength | 40 mg |
| Packing | 30 tablets |
| Manufacturer | Servier Pharmaceuticals |
| Documents | Either PO or prescription |
| Storage | Below 25°C |
| Global delivery time | 10-15 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
| Shipping type | Drop-shipping / direct shipping |
Reviews
There are no reviews yet.